AP2006003823A0 - Indazole and indolone derivatives and their use aspharmaceuticals - Google Patents

Indazole and indolone derivatives and their use aspharmaceuticals

Info

Publication number
AP2006003823A0
AP2006003823A0 AP2006003823A AP2006003823A AP2006003823A0 AP 2006003823 A0 AP2006003823 A0 AP 2006003823A0 AP 2006003823 A AP2006003823 A AP 2006003823A AP 2006003823 A AP2006003823 A AP 2006003823A AP 2006003823 A0 AP2006003823 A0 AP 2006003823A0
Authority
AP
ARIPO
Prior art keywords
aspharmaceuticals
indazole
indolone derivatives
indolone
derivatives
Prior art date
Application number
AP2006003823A
Other languages
English (en)
Inventor
Duncan Charles Miller
David Hepworth
Charlotte Moira Allerton
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411810A external-priority patent/GB0411810D0/en
Priority claimed from GB0415455A external-priority patent/GB0415455D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of AP2006003823A0 publication Critical patent/AP2006003823A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2006003823A 2004-05-26 2005-05-17 Indazole and indolone derivatives and their use aspharmaceuticals AP2006003823A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0411810A GB0411810D0 (en) 2004-05-26 2004-05-26 New indazole and indolone derivatives and their use as pharmaceuticals
GB0415455A GB0415455D0 (en) 2004-07-09 2004-07-09 New indazole and indolone derivatives and their use as pharmaceuticals
PCT/IB2005/001513 WO2005116027A2 (en) 2004-05-26 2005-05-17 Indazole and indolone derivatives and their use as pharmaceuticals

Publications (1)

Publication Number Publication Date
AP2006003823A0 true AP2006003823A0 (en) 2006-12-31

Family

ID=35219654

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003823A AP2006003823A0 (en) 2004-05-26 2005-05-17 Indazole and indolone derivatives and their use aspharmaceuticals

Country Status (25)

Country Link
EP (1) EP1753763B1 (ja)
JP (2) JP4093588B2 (ja)
AP (1) AP2006003823A0 (ja)
AR (1) AR049191A1 (ja)
AT (1) ATE404560T1 (ja)
AU (1) AU2005247696A1 (ja)
BR (1) BRPI0511533A (ja)
CA (1) CA2568050A1 (ja)
CR (1) CR8772A (ja)
DE (1) DE602005008954D1 (ja)
EA (1) EA200601985A1 (ja)
EC (1) ECSP067024A (ja)
ES (1) ES2308492T3 (ja)
GT (1) GT200500118A (ja)
IL (1) IL179365A0 (ja)
MA (1) MA28606B1 (ja)
MX (1) MXPA06013759A (ja)
NL (1) NL1029128C2 (ja)
NO (1) NO20065328L (ja)
PA (1) PA8635001A1 (ja)
PE (1) PE20060289A1 (ja)
SV (1) SV2005002128A (ja)
TW (1) TW200607500A (ja)
UY (1) UY28918A1 (ja)
WO (1) WO2005116027A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR078411A1 (es) 2009-05-07 2011-11-09 Lilly Co Eli Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
US9259409B2 (en) * 2011-01-24 2016-02-16 Inceptum Research & Therapeutics, Inc. Compositions comprising a prostaglandin for treating neuropsychiatric conditions
CA2965741C (en) * 2014-11-03 2022-05-17 Iomet Pharma Ltd Pharmaceutical compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
WO1998035942A1 (en) * 1997-02-18 1998-08-20 American Home Products Corporation 4-aminoethoxyindazole derivatives
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
JP3889775B2 (ja) * 2002-12-10 2007-03-07 ファイザー・インク Ｉ．ａ．性機能障害の治療においてドパミンアゴニストとして使用するためのモルホリン誘導体

Also Published As

Publication number Publication date
AU2005247696A1 (en) 2005-12-08
EP1753763B1 (en) 2008-08-13
MXPA06013759A (es) 2007-02-08
NL1029128C2 (nl) 2006-06-14
WO2005116027A2 (en) 2005-12-08
IL179365A0 (en) 2007-03-08
CR8772A (es) 2006-12-13
SV2005002128A (es) 2005-12-13
CA2568050A1 (en) 2005-12-08
EA200601985A1 (ru) 2007-04-27
NO20065328L (no) 2006-12-18
EP1753763A2 (en) 2007-02-21
BRPI0511533A (pt) 2008-01-02
PE20060289A1 (es) 2006-04-22
NL1029128A1 (nl) 2005-11-30
ATE404560T1 (de) 2008-08-15
AR049191A1 (es) 2006-07-05
TW200607500A (en) 2006-03-01
WO2005116027A3 (en) 2006-04-13
UY28918A1 (es) 2005-12-30
GT200500118A (es) 2006-01-10
JP2008074874A (ja) 2008-04-03
PA8635001A1 (es) 2006-05-16
JP4093588B2 (ja) 2008-06-04
MA28606B1 (fr) 2007-05-02
JP2008500329A (ja) 2008-01-10
ES2308492T3 (es) 2008-12-01
DE602005008954D1 (de) 2008-09-25
ECSP067024A (es) 2006-12-29

Similar Documents

Publication Publication Date Title
IL177704A0 (en) Tetrahydrocarbazoles and derivatives
IL185199A0 (en) Indole compound and use thereof
EP1951215A4 (en) HYDRAZONE DERIVATIVES AND ITS USES
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
IL190806A0 (en) Pyrazole derivatives and their medical use
PT1919894E (pt) Novos derivados de poliquinolinas e a sua utilização terapêutica
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
IL179640A0 (en) Metastin derivatives and use thereof
IL182397A0 (en) Thiazolyl-dihydro indazoles
IL183216A0 (en) Nepetalactams and n-substituted derivatives thereof
IL177260A0 (en) Indazole derivatives and pharmaceutical compositions containing them
IL179747A0 (en) Novel indazole carboxamides and their use
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
EP1737458A4 (en) R (-) - 11-HYDROXYAPORPHINE DERIVATIVES AND USES THEREOF
HK1115584A1 (en) Benzimidazole derivative and use thereof
IL183217A0 (en) Dihydronepetalactams and n-substituted derivatives thereof
AP2007004024A0 (en) Therapeutic pyrazoloÄ3,4-BÜpyridines and indazoles
AP2006003823A0 (en) Indazole and indolone derivatives and their use aspharmaceuticals
EP1911744A4 (en) TRYPTOPHANDERIVATE AND ITS USE
EP1810976A4 (en) BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF
IL185575A0 (en) Benzoxazocines and their therapeutic use
ZA200609836B (en) Indazole and indolone derivatives and their use as pharmaceuticals
GB0415455D0 (en) New indazole and indolone derivatives and their use as pharmaceuticals
EP1863762A4 (en) INDOLE DERIVATIVES AND METHODS USING SAME
ZA200610820B (en) Metastin derivatives and use thereof